Neurocrine Biosciences
NBIX
#1482
Rank
S$15.56 B
Marketcap
$154.16
Share price
-1.75%
Change (1 day)
-1.40%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$1.03 B

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are S$1.03 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$1.34 B51.95%
2022-12-31S$0.88 B-5.94%
2021-12-31S$0.94 B17.1%
2020-12-31S$0.80 B-10.59%
2019-12-31S$0.89 B28.9%
2018-12-31S$0.69 B17.15%
2017-12-31S$0.59 B719.89%
2016-12-31S$72.66 M1.98%
2015-12-31S$71.25 M57.08%
2014-12-31S$45.36 M4.47%
2013-12-31S$43.42 M-14.72%
2012-12-31S$50.91 M-49.78%
2011-12-31S$0.10 B-37.1%
2010-12-31S$0.16 B71.54%
2009-12-31S$93.96 M-19.73%
2008-12-31S$0.11 B-48.74%
2007-12-31S$0.22 B98.69%
2006-12-31S$0.11 B-25.78%
2005-12-31S$0.15 B-16.24%
2004-12-31S$0.18 B-33.69%
2003-12-31S$0.27 B280.04%
2002-12-31S$73.37 M10.23%
2001-12-31S$66.56 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.14 B 10.02%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.29 B 893.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$12.8 M-98.77%๐Ÿ‡บ๐Ÿ‡ธ USA
S$75.85 B 7,218.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$175.99 B 16,878.64%๐Ÿ‡บ๐Ÿ‡ธ USA
S$167.00 B 16,011.84%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.57 B-44.69%๐Ÿ‡บ๐Ÿ‡ธ USA
S$57.08 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA